奥翔药业(603229)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603229 奥翔药业

交易中 05-09 14:40:20

{"stockData":{"symbol":"603229","market":"SH","secType":"STK","nameCN":"奥翔药业","latestPrice":7.97,"timestamp":1746772820000,"preClose":8,"halted":0,"volume":4680344,"delay":0,"changeRate":-0.0038,"floatShares":830000000,"shares":830000000,"eps":0.2572,"marketStatus":"交易中","change":-0.03,"latestTime":"05-09 14:40:20","open":7.99,"high":8.03,"low":7.9,"amount":37241500,"amplitude":0.0162,"askPrice":7.98,"askSize":735,"bidPrice":7.97,"bidSize":52,"shortable":0,"etf":0,"ttmEps":0.2572,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746774000000},"marketStatusCode":2,"adr":0,"adjPreClose":8,"symbolType":"stock","openAndCloseTimeList":[[1746754200000,1746761400000],[1746766800000,1746774000000]],"highLimit":8.8,"lowLimit":7.2,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":830297145,"isCdr":false,"pbRate":2.8,"roa":"--","peRate":30.987558,"roe":"5.11%","epsLYR":0.25,"committee":-0.175639,"marketValue":6617000000,"turnoverRate":0.0056,"status":1,"floatMarketCap":6617000000},"requestUrl":"/m/hq/s/603229","defaultTab":"news","newsList":[{"id":"2533974287","title":"奥翔药业05月08日主力净流入3.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2533974287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533974287?lang=zh_cn&edition=full","pubTime":"2025-05-08 15:19","pubTimestamp":1746688799,"startTime":"0","endTime":"0","summary":"05月08日, 奥翔药业股价涨0.25%，报收8.00元，成交金额4837.2万元，换手率0.73%，振幅1.38%，量比1.00。奥翔药业今日主力资金净流入3.4万元，上一交易日主力净流出40.1万元。该股近5个交易日上涨2.96%，主力资金累计净流出1671.2万元；近20日主力资金累计净流出4210.4万元，其中净流出天数为14日。|05月08日主力加仓幅度排名||#|股票简称|主力净额占比|#|*ST双成|8.61%|#|跨境通|7.99%|#|中百集团|7.29%|#|...|...|#2234|奥翔药业|0.00%|奥翔药业所在的化学制药行业，今日主力净流出8672万元，行业排名42/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508165723a4766d4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508165723a4766d4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2533286279","title":"2025年化学制药行业现状分析：优化工作设计","url":"https://stock-news.laohu8.com/highlight/detail?id=2533286279","media":"报告大厅","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533286279?lang=zh_cn&edition=full","pubTime":"2025-05-08 10:46","pubTimestamp":1746672385,"startTime":"0","endTime":"0","summary":"化学制药行业作业人员的 WMSDs 现状不容乐观，高发生率以及特定的发病部位和影响因素，给行业的职业健康管理带来了挑战。但通过对现状和影响因素的分析可知，2025 年化学制药行业在 WMSDs 防控方面将朝着强化培训、关注特定人群、优化工作设计等方向发展。行业内各方应积极行动起来，采取有效措施，降低作业人员发生 WMSDs 的风险，保障化学制药行业作业人员的身体健康，促进化学制药行业的可持续发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081102469752a909&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505081102469752a909&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229","688505","688321","688758","600488","688513","603676","BK0239","688076","603669","605116","688799","603168"],"gpt_icon":0},{"id":"2533713956","title":"奥翔药业05月07日遭主力抛售40.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533713956","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533713956?lang=zh_cn&edition=full","pubTime":"2025-05-07 15:20","pubTimestamp":1746602402,"startTime":"0","endTime":"0","summary":"05月07日, 奥翔药业股价跌0.13%，报收7.98元，成交金额4541.8万元，换手率0.68%，振幅2.50%，量比0.99。奥翔药业今日主力资金净流出40.1万元，连续5日净流出，上一交易日主力净流出242.3万元。|05月07日主力加仓幅度排名||#|股票简称|主力净额占比|#|*ST精伦|9.01%|#|长华化学|6.32%|#|*ST国华|6.24%|#|...|...|#2135|奥翔药业|-0.01%|奥翔药业所在的化学制药行业，今日主力净流出5.40亿元，行业排名25/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507164223a6d616a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507164223a6d616a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229","BK0239"],"gpt_icon":0},{"id":"2533571530","title":"奥翔药业：累计回购约200万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533571530","media":"每日经济新闻","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533571530?lang=zh_cn&edition=full","pubTime":"2025-05-06 16:35","pubTimestamp":1746520519,"startTime":"0","endTime":"0","summary":"每经AI快讯，奥翔药业（SH 603229，收盘价：7.99元）5月6日晚间发布公告称，截至2025年4月30日，公司通过集中竞价交易方式已累计回购股份约200万股，已回购股份占公司总股本的比例为0.24%，成交的最高价为8.57元/股、最低价为7.52元/股，已支付的总金额约为1554万元。截至发稿，奥翔药业市值为66亿元。每经头条（nbdtoutiao）——空头大撤退！人民币两天爆拉700多点，外汇交易员：外贸传来了好消息(记者 王晓波)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050616363994edbd5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050616363994edbd5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229","BK0239"],"gpt_icon":0},{"id":"2533578910","title":"奥翔药业：已累计回购0.24%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2533578910","media":"格隆汇","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533578910?lang=zh_cn&edition=full","pubTime":"2025-05-06 15:52","pubTimestamp":1746517934,"startTime":"0","endTime":"0","summary":"格隆汇5月6日丨奥翔药业(603229.SH)公布，截至2025年4月30日，公司通过集中竞价交易方式已累计回购股份1,999,400股，已回购股份占公司总股本的比例为0.24%，成交的最高价为8.57元/股、最低价为7.52元/股，已支付的总金额为15,535,845.00元（不含交易费用）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506155214a473aeed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506155214a473aeed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229","BK0239"],"gpt_icon":0},{"id":"2532011172","title":"奥翔药业2025年一季度盈利能力增强但现金流和每股净资产下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2532011172","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532011172?lang=zh_cn&edition=full","pubTime":"2025-05-01 08:33","pubTimestamp":1746059614,"startTime":"0","endTime":"0","summary":"每股指标每股净资产为2.86元，同比减少了25.17%；每股经营性现金流为0元，同比减少了94.58%；每股收益为0.14元，与去年同期持平。总结总体来看，奥翔药业在2025年一季度的盈利能力有所增强，但应收账款的增加、每股净资产的下滑以及每股经营性现金流的大幅减少，提示公司在资金管理和资产质量方面需要进一步优化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501084208a6cf7c65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501084208a6cf7c65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159399","603229","BK0239"],"gpt_icon":0},{"id":"2532901850","title":"奥翔药业（603229）2025年一季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2532901850","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532901850?lang=zh_cn&edition=full","pubTime":"2025-05-01 06:26","pubTimestamp":1746051994,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期奥翔药业发布2025年一季报。截至本报告期末，公司营业总收入3.07亿元，同比上升1.9%，归母净利润1.19亿元，同比上升5.97%。本报告期奥翔药业盈利能力上升，毛利率同比增幅4.68%，净利率同比增幅4%。去年的净利率为26%，算上全部成本后，公司产品或服务的附加值高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050100003711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603229"],"gpt_icon":0},{"id":"2531170710","title":"奥翔药业截止03月31日股东人数3.08万户，人均持股2.70万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2531170710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531170710?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:32","pubTimestamp":1745998344,"startTime":"0","endTime":"0","summary":"奥翔药业披露公司股东人数最新情况，截止2025年03月31日，公司股东人数为3.08万户，较上期增加706户，环比减少27.3%。在化学制药行业个股中，奥翔药业股东户数少于行业平均水平，截至2025年03月31日，化学制药行业平均股东户数为3.45万户，户均持股市值方面，化学制药行业A股上市公司户均持股市值为76.47万元，奥翔药业少于行业平均水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430165633a46d6f92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430165633a46d6f92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2531729487","title":"奥翔药业一季度营收同比增长1.9%，归母净利润1.19亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531729487","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531729487?lang=zh_cn&edition=full","pubTime":"2025-04-30 10:52","pubTimestamp":1745981575,"startTime":"0","endTime":"0","summary":"4月29日，奥翔药业公布2025年一季报，公司营业收入为3.07亿元，同比上升1.9%；归母净利润为1.19亿元，同比上升6.0%；扣非归母净利润为1.12亿元，同比上升2.8%；经营现金流净额为205万元，同比下降92.4%；EPS为0.1436元。截至一季度末，公司总资产31.21亿元，较上年度末增长4.6%；归母净资产为23.72亿元，较上年度末增长4.4%。文章来源：财中社奥翔药业一季度营收同比增长1.9%，归母净利润1.19亿元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430112004a46d1222&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430112004a46d1222&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229"],"gpt_icon":0},{"id":"2531738758","title":"奥翔药业(603229.SH)发布一季度业绩，归母净利润1.19亿元，同比增长5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531738758","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531738758?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:39","pubTimestamp":1745933940,"startTime":"0","endTime":"0","summary":"奥翔药业(603229.SH)披露2025年第一季度报告，报告期公司实现营收3.07亿元，同比增长1.90%;归母净利润1.19亿元，同比增长5.97%;扣非净利润1.12亿元，同比增长2.81%。基本每股收益0.14元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-29/doc-ineuvxpn4051667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603229"],"gpt_icon":0},{"id":"2531788290","title":"奥翔药业：2025年第一季度净利润1.19亿元 同比增长5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531788290","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531788290?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:17","pubTimestamp":1745921820,"startTime":"0","endTime":"0","summary":"南财智讯4月29日电，奥翔药业发布2025年第一季度报告，报告期实现营业收入3.07亿元，同比增长1.90%；归属上市公司股东的净利润1.19亿元，同比增长5.97%；扣除非经常性损益后的归属于上市公司股东的净利润1.12亿元，同比增长2.81%；基本每股收益0.14元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429181839a6cd1b36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429181839a6cd1b36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229"],"gpt_icon":0},{"id":"2531202863","title":"奥翔药业一季度净利润1.19亿元，同比增长5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531202863","media":"格隆汇资讯","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531202863?lang=zh_cn&edition=full","pubTime":"2025-04-29 17:47","pubTimestamp":1745920031,"startTime":"0","endTime":"0","summary":"格隆汇4月29日丨奥翔药业(603229.SH)发布一季报，2025年一季度实现营业总收入3.07亿元，同比增长1.9%；归属母公司股东净利润1.19亿元，同比增长5.97%；基本每股收益为0.14元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504291747319749f2c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504291747319749f2c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"奥翔药业一季度净利润1.19亿元，同比增长5.97%","news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229"],"gpt_icon":0},{"id":"2530540538","title":"奥翔药业04月28日主力净流出146.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2530540538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530540538?lang=zh_cn&edition=full","pubTime":"2025-04-28 19:26","pubTimestamp":1745839603,"startTime":"0","endTime":"0","summary":"04月28日, 奥翔药业股价跌1.27%，报收7.77元，成交金额3275.7万元，换手率0.51%，振幅1.91%，量比0.71。奥翔药业今日主力资金净流出146.0万元，上一交易日主力净流入98.0万元。该股近5个交易日下跌0.38%，主力资金累计净流出149.0万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出3635.0万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428200039a46a6ac5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428200039a46a6ac5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229","BK0239"],"gpt_icon":0},{"id":"2529217155","title":"奥翔药业04月23日主力净流出457万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2529217155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529217155?lang=zh_cn&edition=full","pubTime":"2025-04-23 15:22","pubTimestamp":1745392938,"startTime":"0","endTime":"0","summary":"04月23日, 奥翔药业股价跌1.25%，报收7.90元，成交金额4771万元，换手率0.72%，振幅2.50%，量比0.98。奥翔药业今日主力资金净流出457万元，上一交易日主力净流入424万元。该股近5个交易日上涨2.86%，主力资金累计净流出554万元；近20日主力资金累计净流出4658万元，其中净流出天数为13日。|04月23日主力加仓幅度排名||#|股票简称|主力净额占比|#|健尔康|8.43%|#|新天地|7.95%|#|利安科技|7.56%|#|...|...|#3532|奥翔药业|-0.07%|奥翔药业所在的化学制药行业，今日主力净流出1.78亿元，行业排名28/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423164215a6c4e8b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423164215a6c4e8b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2529834925","title":"奥翔药业04月22日主力净流入424万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529834925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529834925?lang=zh_cn&edition=full","pubTime":"2025-04-22 15:19","pubTimestamp":1745306356,"startTime":"0","endTime":"0","summary":"04月22日, 奥翔药业股价涨2.56%，报收8.00元，成交金额7147万元，换手率1.09%，振幅3.72%，量比1.65。奥翔药业今日主力资金净流入424万元，上一交易日主力净流出193万元。该股近5个交易日上涨2.17%，主力资金累计净流入58万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出4400万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422154528a4621d66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422154528a4621d66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603229"],"gpt_icon":0},{"id":"2529588153","title":"化学制药行业盘中拉升，威尔药业涨9.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529588153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529588153?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:44","pubTimestamp":1745286262,"startTime":"0","endTime":"0","summary":"04月22日，化学制药行业盘中拉升，截至09点44分，化学制药行业整体指数上涨1.01%，报10985.070点。从个股上来看，该行业的成分股中，威尔药业涨9.09%，富祥药业、东诚药业等4只股涨幅超过5%。从资金上来看，截止发稿，化学制药行业主力净流入为-1.59亿，其中东诚药业受到资金热捧，主力净流入2513.18万；拉长时间线来看，该板块近20日主力资金净流入-68.34亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094422a6c316d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094422a6c316d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688189","600267","600488","688356","600521","688566","600513","688578","603229","600624","BK0060","600276","600216","600789","688799","600196","605507","600812","688247","603538","600380","600420","603811","688513","BK0188","605116","603707","688076","688091","BK0275","688690","605177","688505","603351","688117","600613","688506","688166","BK0028","603676"],"gpt_icon":0},{"id":"2529809163","title":"美国关税或致药品短缺？行业警告：低利润仿制药面临停产危机","url":"https://stock-news.laohu8.com/highlight/detail?id=2529809163","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529809163?lang=zh_cn&edition=full","pubTime":"2025-04-21 18:06","pubTimestamp":1745230017,"startTime":"0","endTime":"0","summary":"特朗普口中的“关税武器”，瞄准了全球仰赖的仿制药供应链。据央视新闻，美国或对进口药品征收关税。特朗普多次放话，药品可能被纳入征税范围。本周，美国商务部也宣布对药品进口是否构成“国家安全风险”启动调查。要知道，仿制药承担了美国约90%的药品供应，本身利润就极其微薄，加征关税一旦成真，部分药企或直接停产。目前美国大部分仿制药产自印度和东南亚，美国很难自给自足。事实上，美国药品供应紧张早已有苗头。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421180725a6c227a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421180725a6c227a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688247","600624","688356","603168","600664","688513","603707","600276","688076","688506","688799","BK0239","600521","603351","688578","600812","688166","600789","600267","603811","688566","603538","600774","600079","603229","603207","605116","688758","688321","603669","603676","600613"],"gpt_icon":0},{"id":"2528030316","title":"奥翔药业04月18日遭主力抛售243万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528030316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528030316?lang=zh_cn&edition=full","pubTime":"2025-04-18 15:21","pubTimestamp":1744960895,"startTime":"0","endTime":"0","summary":"04月18日, 奥翔药业股价跌0.39%，报收7.66元，成交金额2937万元，换手率0.46%，振幅2.34%，量比0.61。奥翔药业今日主力资金净流出243万元，上一交易日主力净流出88万元。该股主力净额占比0.04%，A股市场排名3269/5412，低于行业平均值。|04月18日主力加仓幅度排名||#|股票简称|主力净额占比|#|亚联机械|6.61%|#|永杰新材|6.36%|#|三夫户外|6.18%|#|...|...|#3269|奥翔药业|-0.04%|奥翔药业所在的化学制药行业，今日主力净流出7373万元，行业排名64/124。净流出前三个股分别为双成药业、恒瑞医药、一品红。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418163358a6bf130f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418163358a6bf130f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229","BK0239"],"gpt_icon":0},{"id":"2518721557","title":"奥翔药业03月10日主力净流入372万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2518721557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518721557?lang=zh_cn&edition=full","pubTime":"2025-03-10 15:22","pubTimestamp":1741591350,"startTime":"0","endTime":"0","summary":"03月10日, 奥翔药业股价涨0.82%，报收8.61元，成交金额7132万元，换手率1.00%，振幅2.11%，量比1.01。奥翔药业今日主力资金净流入372万元，上一交易日主力净流出345万元。该股近5个交易日下跌0.69%，主力资金累计净流出2432万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出7922万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310164828a269b463&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310164828a269b463&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603229","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746772824311,"stockEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.0526},{"period":"3month","weight":-0.095},{"period":"6month","weight":-0.0815},{"period":"1year","weight":-0.0453},{"period":"ytd","weight":-0.1992}],"compareEarnings":[{"period":"1week","weight":0.0223},{"period":"1month","weight":0.0656},{"period":"3month","weight":0.0146},{"period":"6month","weight":-0.0291},{"period":"1year","weight":0.0714},{"period":"ytd","weight":0.0001}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江奥翔药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"30806人(较上一季度减少27.30%)","perCapita":"26952股","listingDate":"2017-05-09","address":"浙江省台州市临海市化学原料药基地临海园区东海第四大道5号","registeredCapital":"83029万元","survey":"　　浙江奥翔药业股份有限公司的主营业务是从事制剂、特色原料药及医药中间体的研发、生产与销售，以及为客户提供定制生产和研发业务。公司的主要产品是肝病类、抗菌类、心脑血管类、前列腺素类、高端氟产品类、痛风类、抗肿瘤类、神经系统类、其他类。目前，公司的成熟产品已有双环醇、恩替卡韦、西他沙星、泊沙康唑、非布司他、奈必洛尔、米格列醇等。经过多年化学合成的生产经验积累和技术工艺研发创新，公司形成了以合成装备完整先进、合成工艺成熟丰富、产业化能力强以及质量控制规范等为特征的化学原料药生产制造能力优势。","listedPrice":7.81},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥翔药业(603229)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥翔药业(603229)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥翔药业,603229,奥翔药业股票,奥翔药业股票老虎,奥翔药业股票老虎国际,奥翔药业行情,奥翔药业股票行情,奥翔药业股价,奥翔药业股市,奥翔药业股票价格,奥翔药业股票交易,奥翔药业股票购买,奥翔药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥翔药业(603229)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥翔药业(603229)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}